✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Sahajanand Medical Technologies Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Sahajanand Medical is 0

Growth Table
  • Sahajanand Medical Technologies Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet
  • Sahajanand Medical Technologies Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sahajanand Medical Technologies Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow
  • Sahajanand Medical Technologies Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sahajanand Medical Technologies Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Sahajanand Medical Technologies Ltd. Financials

Sahajanand Medical balance sheet is weak and might have solvency issues

Yes, The debt of Sahajanand Medical is increasing.
Latest debt of Sahajanand Medical is ₹45.13 Crs as of Mar-21.
This is greater than Mar-20 when it was -₹38.45 Crs.

No, profit is decreasing.
The profit of Sahajanand Medical is -₹72.31 Crs for Mar 2021, ₹24.56 Crs for Mar 2020 and ₹43.3 Crs for Mar 2019

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sahajanand Medical latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech